Obesity leaves long-lasting epigenetic imprints on the human immune system that can persist for years after significant weight loss. Research from the University of Birmingham indicates that these molecular markers in CD4 T-helper cells may contribute to ongoing metabolic dysfunction and inflammation, potentially explaining why the health risks of obesity do not disappear immediately upon shedding weight.
Epigenetic Memory in Immune Cells
Prof. Claudio Mauro and his team at the University of Birmingham identified that obesity induces specific DNA-methylation patterns in CD4 T-helper cells. These molecular changes, often described as a form of "cellular memory," remain detectable even after weight loss achieved through medication, genetic intervention, or dietary changes.
According to research findings, the immune system undergoes distinct shifts when exposed to different fatty acids. Saturated fatty acids like palmitate alter the membranes of CD4 cells, while other fatty acids, such as oleic acid, produce different cellular effects. The research team estimates that this cellular memory may take five to ten years to fully fade, though they emphasize that further long-term clinical studies are required to confirm this timeline. These persistent epigenetic marks may explain why individuals remain at risk for type 2 diabetes and certain cancers even after their body mass index (BMI) has decreased.
Limits of Lifestyle Intervention
The University of Birmingham study highlighted the limitations of conventional exercise programs. In their research, a ten-week training regimen proved insufficient to "reset" the epigenetic memory stored within CD4 cells in both blood and adipose tissue. This suggests that while exercise is beneficial for overall health, it may not be enough to reverse deep-seated immunological changes caused by long-term obesity.
Reversal Through Bariatric Surgery
A contrasting set of data from the University of Leipzig, published in the International Journal of Obesity, demonstrates that more intensive interventions can trigger a measurable reset of the immune system. Researchers led by Ulf Wagner examined 111 individuals with a mean BMI of 48.4 before they underwent bariatric surgery.
Twelve months post-operation, with an average weight loss of 44.5 kilograms, the researchers observed a normalization of monocyte subpopulations and CD16 expression. These physiological improvements were accompanied by better clinical markers, including HbA1c, lipid levels, and C-reactive protein (CRP). The study concluded that while mild weight loss through lifestyle changes failed to alter these specific immune markers, the rapid and significant weight reduction associated with bariatric surgery successfully restored them.
Emerging Immunological Therapies
Because lifestyle changes alone may not rapidly clear the immune system’s "memory" of obesity, scientists are exploring pharmacological approaches. SGLT2 inhibitors, currently used to treat type 2 diabetes, are being investigated for their potential to accelerate the removal of these epigenetic modifications.
Preliminary evidence from the Vanderbilt University supports the potential for targeted drug therapy. In a study of 16 women with obesity and prediabetes, the administration of the SGLT2 inhibitor empagliflozin led to a measurable reduction in monocyte-platelet aggregates within two weeks. By the three-month mark, the study showed a shift in monocyte metabolism from an inflammatory state to a stable energy state. Researchers plan to conduct further trials, including a double-blind study in Leipzig involving 200 insulin-resistant participants, to evaluate the effectiveness of colchicine and interleukin-1 inhibitors in managing this immunological burden.
Frequently Asked Questions
Why does the immune system retain a memory of obesity?
The immune system adapts to the metabolic environment created by obesity, specifically through DNA methylation in CD4 T-helper cells. These epigenetic changes act as a persistent biological record of the body’s previous state, which can continue to drive inflammation even after weight is lost.
Can diet alone reverse these immune changes?
Current research indicates that mild weight loss via lifestyle adjustments is often insufficient to normalize immune markers like monocytes. Significant, rapid weight loss—such as that achieved through bariatric surgery—appears more effective at resetting these specific immunological dysfunctions.
Are there medications that can speed up the recovery of the immune system?
Clinical trials are currently underway to test whether drugs like SGLT2 inhibitors or anti-inflammatory agents can clear these epigenetic imprints. While initial studies show promise in shifting monocytes toward a healthier metabolic state, more large-scale human trials are needed to confirm these treatments as a standard approach.
Related reading